Healthcare Sector Stocks
The Healthcare sector has a total of 1046 stocks, with a combined market cap of $9.06 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 47.37.
Market Cap
9.06T
Revenue
4.67T
Profits
191.22B
PE Ratio
47.37
Profit Margin
4.10%
Dividend Yield
0.39%
1046 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.02T | -0.62% | 2,172,914 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 623.34B | -2.30% | 8,290,211 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 459.33B | -0.63% | 3,891,990 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 354.80B | -1.03% | 7,856,278 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 327.80B | -0.51% | 3,942,237 | 450.53B |
| 6 | NVS | Novartis AG | 270.16B | -1.07% | 2,056,221 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 246.55B | -2.33% | 3,378,026 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 241.26B | -3.34% | 2,375,293 | 46.34B |
| 9 | AMGN | Amgen Inc. | 220.18B | -3.38% | 2,500,631 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 182.89B | -1.04% | 4,437,587 | 30.46B |
| 11 | ABT | Abbott Laboratories | 167.31B | -2.17% | 8,861,635 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 166.45B | -1.35% | 10,834,430 | 50.34B |
| 13 | PFE | Pfizer Inc. | 160.27B | -1.40% | 30,483,831 | 63.70B |
| 14 | DHR | Danaher Corporation | 148.86B | -4.42% | 5,291,811 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 141.75B | -1.33% | 1,511,225 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 128.44B | -3.07% | 1,194,377 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 125.55B | -1.51% | 8,223,534 | 49.19B |
| 18 | MDT | Medtronic plc | 110.57B | 0.17% | 29,277,475 | 37.54B |
| 19 | CVS | CVS Health Corporation | 108.97B | -0.57% | 6,529,757 | 412.65B |
| 20 | MCK | McKesson Corporation | 104.79B | 5.27% | 1,210,102 | 410.98B |
| 21 | SYK | Stryker Corporation | 104.70B | -0.88% | 2,463,953 | 25.84B |
| 22 | SNY | Sanofi | 98.60B | -1.36% | 6,683,141 | 55.89B |
| 23 | GSK | GSK plc | 95.02B | -2.06% | 7,897,493 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 91.66B | -0.79% | 839,530 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 82.77B | -1.84% | 855,522 | 201.11B |
| 26 | MRNA | Moderna, Inc. | 75.43B | -1.89% | 15,475,207 | 2.23B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 73.37B | -3.09% | 1,042,688 | 15.53B |
| 28 | CI | The Cigna Group | 70.81B | -1.42% | 1,632,033 | 282.38B |
| 29 | BSX | Boston Scientific Corporation | 62.65B | -0.96% | 14,201,705 | 21.00B |
| 30 | ARGX | argenx SE | 59.26B | -2.39% | 302,243 | 5.32B |
| 31 | COR | Cencora, Inc. | 59.11B | 3.17% | 1,378,077 | 332.77B |
| 32 | NTRA | Natera, Inc. | 58.88B | -1.17% | 1,863,498 | 2.71B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 58.10B | -1.81% | 2,257,241 | 28.42B |
| 34 | CAH | Cardinal Health, Inc. | 53.28B | 3.65% | 1,361,115 | 254.25B |
| 35 | EW | Edwards Lifesciences Corporation | 49.10B | -1.31% | 2,489,294 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 48.50B | -0.52% | 1,287,875 | 22.48B |
| 37 | A | Agilent Technologies, Inc. | 46.99B | -3.27% | 2,787,272 | 7.37B |
| 38 | MDLN | Medline Inc. | 45.94B | 0.69% | 11,732,747 | 29.94B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 45.81B | -0.73% | 5,986,875 | 17.32B |
| 40 | VEEV | Veeva Systems Inc. | 45.65B | -1.23% | 961,317 | 3.46B |
| 41 | HUM | Humana Inc. | 45.59B | -0.50% | 727,873 | 145.68B |
| 42 | RVMD | Revolution Medicines, Inc. | 44.13B | 0.31% | 2,104,249 | - |
| 43 | IQV | IQVIA Holdings Inc. | 42.91B | -3.02% | 1,250,504 | 16.98B |
| 44 | WAT | Waters Corporation | 41.81B | -3.15% | 590,382 | 4.64B |
| 45 | ONC | BeOne Medicines AG | 40.79B | -1.96% | 351,441 | 6.13B |
| 46 | IDXX | IDEXX Laboratories, Inc. | 40.79B | -0.85% | 320,309 | 4.55B |
| 47 | ILMN | Illumina, Inc. | 40.12B | -2.91% | 1,950,783 | 4.49B |
| 48 | HLN | Haleon plc | 38.15B | -3.11% | 26,626,730 | 14.80B |
| 49 | RPRX | Royalty Pharma plc | 33.14B | -1.25% | 3,245,214 | 2.54B |
| 50 | BIIB | Biogen Inc. | 32.92B | -1.35% | 1,795,331 | 10.03B |
| 51 | DXCM | DexCom, Inc. | 32.54B | -0.07% | 3,034,542 | 4.97B |
| 52 | RMD | ResMed Inc. | 31.64B | 0.02% | 945,420 | 5.65B |
| 53 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.93B | -6.31% | 2,015,405 | 4.80B |
| 54 | ALC | Alcon Inc. | 30.76B | -1.25% | 2,037,741 | 10.86B |
| 55 | CNC | Centene Corporation | 30.13B | -1.82% | 5,302,752 | 180.30B |
| 56 | MTD | Mettler-Toledo International Inc. | 29.68B | -1.97% | 167,663 | 4.13B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 28.90B | -2.13% | 3,328,613 | 21.27B |
| 58 | ZTS | Zoetis Inc. | 28.55B | -1.05% | 5,347,074 | 9.53B |
| 59 | WST | West Pharmaceutical Services, Inc. | 25.69B | -1.55% | 473,472 | 3.33B |
| 60 | ROIV | Roivant Sciences Ltd. | 25.64B | -2.93% | 3,258,237 | 7.53M |
| 61 | DGX | Quest Diagnostics Incorporated | 25.51B | -0.85% | 762,153 | 11.56B |
| 62 | LH | Labcorp Holdings Inc. | 24.70B | -1.14% | 468,668 | 14.35B |
| 63 | UTHR | United Therapeutics Corporation | 24.51B | 5.44% | 1,691,478 | 3.15B |
| 64 | BNTX | BioNTech SE | 24.33B | -1.48% | 788,065 | 3.03B |
| 65 | INCY | Incyte Corporation | 23.74B | -3.47% | 2,364,813 | 5.82B |
| 66 | INSM | Insmed Incorporated | 23.71B | -4.86% | 2,646,445 | 1.14B |
| 67 | GH | Guardant Health, Inc. | 23.45B | -2.02% | 1,960,794 | 1.18B |
| 68 | PHG | Koninklijke Philips N.V. | 23.33B | -2.54% | 1,272,177 | 20.18B |
| 69 | GMAB | Genmab A/S | 20.81B | -3.15% | 6,376,493 | 4.13B |
| 70 | THC | Tenet Healthcare Corporation | 20.45B | -0.62% | 331,166 | 21.81B |
| 71 | STE | STERIS plc | 20.41B | -0.32% | 409,447 | 6.04B |
| 72 | VTRS | Viatris Inc. | 20.05B | -1.47% | 9,038,822 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 16.80B | -0.87% | 1,649,982 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 16.69B | -4.18% | 233,384 | 2.78B |
| 75 | RVTY | Revvity, Inc. | 16.63B | -2.51% | 2,065,107 | 2.91B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.13B | 0.64% | 740,379 | 4.60B |
| 77 | SOLV | Solventum Corporation | 14.94B | -0.43% | 528,848 | 8.31B |
| 78 | ASND | Ascendis Pharma A/S | 14.91B | -0.36% | 805,893 | 1.20B |
| 79 | EXEL | Exelixis, Inc. | 14.36B | -0.80% | 1,369,440 | 2.44B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 14.30B | -0.80% | 2,051,992 | 3.37B |
| 81 | TEM | Tempus AI, Inc. | 13.80B | -6.59% | 7,172,553 | 1.43B |
| 82 | CRL | Charles River Laboratories International, Inc. | 13.69B | -2.77% | 523,793 | 4.00B |
| 83 | SMMT | Summit Therapeutics Inc. | 13.31B | -1.30% | 7,900,229 | - |
| 84 | BBIO | BridgeBio Pharma, Inc. | 13.08B | 1.69% | 3,550,063 | 713.07M |
| 85 | PEN | Penumbra, Inc. | 12.53B | -0.11% | 304,292 | 1.50B |
| 86 | ICLR | ICON Public Limited Company | 12.49B | -4.79% | 677,179 | 8.29B |
| 87 | CORT | Corcept Therapeutics Incorporated | 12.33B | -1.05% | 878,985 | 830.81M |
| 88 | BAX | Baxter International Inc. | 12.22B | -1.50% | 4,981,845 | 11.47B |
| 89 | HALO | Halozyme Therapeutics, Inc. | 12.14B | -3.13% | 2,329,070 | 1.66B |
| 90 | BTSG | BrightSpring Health Services, Inc. | 11.93B | 0.90% | 2,465,143 | 14.37B |
| 91 | FMS | Fresenius Medical Care AG | 11.84B | -0.54% | 468,873 | 22.19B |
| 92 | TWST | Twist Bioscience Corporation | 11.79B | -2.69% | 3,115,941 | 431.80M |
| 93 | EHC | Encompass Health Corporation | 11.75B | -1.83% | 614,367 | 6.21B |
| 94 | TXG | 10x Genomics, Inc. | 11.56B | -1.77% | 3,250,067 | 616.91M |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.55B | -0.84% | 204,561 | 1.28B |
| 96 | TECH | Bio-Techne Corporation | 11.35B | -0.10% | 2,711,395 | 1.22B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 11.31B | -2.60% | 1,596,885 | 3.41B |
| 98 | DVA | DaVita Inc. | 11.25B | 0.82% | 533,948 | 14.01B |
| 99 | SNN | Smith & Nephew plc | 10.92B | -1.41% | 1,601,097 | 6.30B |
| 100 | COO | The Cooper Companies, Inc. | 10.92B | 1.56% | 4,897,447 | 4.24B |
| 101 | ELAN | Elanco Animal Health Incorporated | 10.88B | -2.77% | 5,089,125 | 5.02B |
| 102 | RDY | Dr. Reddy's Laboratories Limited | 10.38B | -2.93% | 2,949,457 | 3.50B |
| 103 | ALGN | Align Technology, Inc. | 10.33B | - | 619,777 | 4.14B |
| 104 | UHS | Universal Health Services, Inc. | 10.32B | 0.46% | 453,173 | 18.11B |
| 105 | AVTR | Avantor, Inc. | 10.17B | -0.13% | 8,795,013 | 6.56B |
| 106 | RGEN | Repligen Corporation | 10.00B | -7.80% | 1,945,673 | 785.10M |
| 107 | GMED | Globus Medical, Inc. | 9.99B | -0.65% | 1,190,556 | 3.14B |
| 108 | IBRX | ImmunityBio, Inc. | 9.84B | -1.69% | 12,307,332 | 165.79M |
| 109 | ENSG | The Ensign Group, Inc. | 9.80B | -1.38% | 432,522 | 5.49B |
| 110 | KRYS | Krystal Biotech, Inc. | 9.63B | -2.18% | 225,684 | 440.48M |
| 111 | GKOS | Glaukos Corporation | 9.62B | -0.62% | 611,232 | 612.84M |
| 112 | AXSM | Axsome Therapeutics, Inc. | 9.54B | -1.26% | 660,096 | 776.57M |
| 113 | BIO | Bio-Rad Laboratories, Inc. | 9.51B | -5.86% | 219,273 | 2.59B |
| 114 | HSIC | Henry Schein, Inc. | 9.47B | 1.14% | 1,025,580 | 13.60B |
| 115 | BRKR | Bruker Corporation | 9.44B | -4.34% | 2,377,912 | 3.50B |
| 116 | MOH | Molina Healthcare, Inc. | 9.42B | -4.36% | 1,046,250 | 42.47B |
| 117 | OSCR | Oscar Health, Inc. | 9.22B | -3.05% | 2,982,587 | 15.32B |
| 118 | KYMR | Kymera Therapeutics, Inc. | 9.16B | -1.49% | 1,051,064 | 105.00M |
| 119 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.15B | -1.01% | 1,522,217 | 669.50M |
| 120 | CYTK | Cytokinetics, Incorporated | 9.12B | -0.44% | 1,724,306 | 67.67M |
| 121 | PODD | Insulet Corporation | 9.07B | 0.25% | 3,257,416 | 3.05B |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 9.00B | -1.29% | 886,233 | 281.99M |
| 123 | QGEN | Qiagen N.V. | 8.69B | -3.93% | 1,918,190 | 2.10B |
| 124 | PCVX | Vaxcyte, Inc. | 8.34B | -1.49% | 1,166,164 | - |
| 125 | ABVX | ABIVAX Société Anonyme | 8.26B | -3.96% | 1,244,242 | 5.33M |
| 126 | CAI | Caris Life Sciences, Inc. | 8.01B | -7.44% | 4,407,363 | 989.61M |
| 127 | PRAX | Praxis Precision Medicines, Inc. | 8.01B | -1.48% | 368,715 | 7.46M |
| 128 | SYRE | Spyre Therapeutics, Inc. | 7.93B | 1.01% | 1,662,567 | - |
| 129 | HNGE | Hinge Health, Inc. | 7.90B | 0.72% | 1,415,677 | 720.06M |
| 130 | ATR | AptarGroup, Inc. | 7.69B | -0.24% | 290,444 | 3.93B |
| 131 | TGTX | TG Therapeutics, Inc. | 7.61B | -3.87% | 1,859,219 | 799.54M |
| 132 | HQY | HealthEquity, Inc. | 7.39B | 1.03% | 726,532 | 1.36B |
| 133 | IONS | Ionis Pharmaceuticals, Inc. | 7.31B | -1.46% | 2,030,075 | 874.09M |
| 134 | AMRX | Amneal Pharmaceuticals, Inc. | 6.99B | -0.35% | 3,936,110 | 3.12B |
| 135 | IMVT | Immunovant, Inc. | 6.95B | -0.38% | 1,671,764 | - |
| 136 | HIMS | Hims & Hers Health, Inc. | 6.84B | -1.64% | 7,164,203 | 2.58B |
| 137 | ALKS | Alkermes plc | 6.80B | 0.05% | 2,626,366 | 1.67B |
| 138 | BLTE | Belite Bio, Inc | 6.56B | -4.03% | 198,812 | - |
| 139 | CHE | Chemed Corporation | 6.55B | -0.43% | 177,897 | 2.60B |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.50B | 0.12% | 617,060 | 1.56B |
| 141 | PACS | PACS Group, Inc. | 6.50B | -1.25% | 698,951 | 5.55B |
| 142 | GRFS | Grifols, S.A. | 6.45B | -0.14% | 623,126 | 8.48B |
| 143 | IOVA | Iovance Biotherapeutics, Inc. | 6.45B | -3.98% | 15,018,733 | 324.97M |
| 144 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.43B | -1.90% | 850,606 | 239.92M |
| 145 | KOD | Kodiak Sciences Inc. | 6.18B | 3.86% | 3,793,257 | - |
| 146 | CGON | CG Oncology, Inc. | 6.06B | -3.58% | 984,865 | 6.23M |
| 147 | BLCO | Bausch + Lomb Corporation | 6.05B | -0.35% | 537,573 | 5.32B |
| 148 | LGND | Ligand Pharmaceuticals Incorporated | 6.04B | -3.08% | 430,879 | 290.54M |
| 149 | GRAL | GRAIL, Inc. | 5.92B | -5.40% | 1,089,663 | 165.26M |
| 150 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.87B | 0.82% | 878,541 | 840.85M |
| 151 | SRRK | Scholar Rock Holding Corporation | 5.62B | -4.47% | 1,061,424 | - |
| 152 | ORKA | Oruka Therapeutics, Inc. | 5.52B | 0.16% | 921,011 | - |
| 153 | MMED | MiniMed Group, Inc. | 5.51B | 0.67% | 3,933,118 | 3.22B |
| 154 | COGT | Cogent Biosciences, Inc. | 5.48B | -1.34% | 1,698,567 | - |
| 155 | STVN | Stevanato Group S.p.A. | 5.46B | -4.77% | 172,907 | 1.40B |
| 156 | MIRM | Mirum Pharmaceuticals, Inc. | 5.45B | -1.82% | 641,714 | 618.07M |
| 157 | CRSP | CRISPR Therapeutics AG | 5.36B | 0.22% | 1,050,262 | 13.39M |
| 158 | TVTX | Travere Therapeutics, Inc. | 5.36B | -3.45% | 1,777,752 | 591.33M |
| 159 | PTCT | PTC Therapeutics, Inc. | 5.35B | -1.00% | 1,197,747 | 1.01B |
| 160 | TFX | Teleflex Incorporated | 5.34B | 0.86% | 621,294 | 2.25B |
| 161 | RDNT | RadNet, Inc. | 5.33B | -1.80% | 928,737 | 2.27B |
| 162 | SHC | Sotera Health Company | 5.17B | -2.00% | 1,641,146 | 1.22B |
| 163 | MMSI | Merit Medical Systems, Inc. | 5.14B | -0.09% | 701,749 | 1.58B |
| 164 | ERAS | Erasca, Inc. | 5.10B | -0.55% | 2,784,672 | - |
| 165 | DOCS | Doximity, Inc. | 5.08B | 0.56% | 3,332,363 | 655.57M |
| 166 | DFTX | Definium Therapeutics, Inc. | 5.05B | -1.21% | 1,873,985 | - |
| 167 | BLLN | BillionToOne, Inc. | 4.99B | -0.64% | 586,944 | 397.41M |
| 168 | DNTH | Dianthus Therapeutics, Inc. | 4.94B | 0.31% | 767,032 | 1.90M |
| 169 | MANE | Veradermics, Incorporated | 4.90B | -3.31% | 659,741 | - |
| 170 | WAY | Waystar Holding Corp. | 4.86B | 0.04% | 1,930,233 | 1.21B |
| 171 | HAE | Haemonetics Corporation | 4.75B | -0.88% | 355,707 | 1.35B |
| 172 | LFST | LifeStance Health Group, Inc. | 4.55B | -1.00% | 3,708,768 | 1.58B |
| 173 | ABCL | AbCellera Biologics Inc. | 4.51B | -4.66% | 7,783,495 | 66.17M |
| 174 | CON | Concentra Group Holdings Parent, Inc. | 4.46B | 1.60% | 700,007 | 2.29B |
| 175 | EWTX | Edgewise Therapeutics, Inc. | 4.40B | -0.30% | 1,286,680 | - |
| 176 | ADPT | Adaptive Biotechnologies Corporation | 4.37B | -5.29% | 6,018,736 | 308.08M |
| 177 | ITGR | Integer Holdings Corporation | 4.30B | 0.06% | 354,306 | 1.84B |
| 178 | HTFL | HeartFlow, Inc. | 4.25B | -1.69% | 965,245 | 212.07M |
| 179 | INDV | Indivior Pharmaceuticals, Inc. | 4.18B | -1.31% | 1,879,039 | 1.33B |
| 180 | TNGX | Tango Therapeutics, Inc. | 4.12B | -2.00% | 2,910,121 | 53.81M |
| 181 | LIVN | LivaNova PLC | 4.12B | -2.35% | 767,261 | 1.47B |
| 182 | RLAY | Relay Therapeutics, Inc. | 4.05B | 2.44% | 2,222,525 | 10.35M |
| 183 | ICUI | ICU Medical, Inc. | 3.93B | -2.11% | 248,202 | 2.16B |
| 184 | XENE | Xenon Pharmaceuticals Inc. | 3.77B | 4.68% | 3,660,080 | 7.50M |
| 185 | PBLS | Parabilis Medicines, Inc. | 3.76B | -5.73% | 885,842 | 148.00K |
| 186 | LEGN | Legend Biotech Corporation | 3.74B | -2.87% | 2,223,285 | 1.27B |
| 187 | NVST | Envista Holdings Corporation | 3.72B | -1.32% | 1,839,306 | 2.86B |
| 188 | CELC | Celcuity Inc. | 3.68B | -5.52% | 1,096,846 | - |
| 189 | TLX | Telix Pharmaceuticals Limited | 3.67B | -2.28% | 201,696 | 890.79M |
| 190 | IRTC | iRhythm Holdings, Inc. | 3.66B | -2.30% | 373,965 | 825.34M |
| 191 | IDYA | IDEAYA Biosciences, Inc. | 3.65B | -1.59% | 488,591 | 234.13M |
| 192 | OGN | Organon & Co. | 3.60B | 0.07% | 1,781,518 | 6.13B |
| 193 | VKTX | Viking Therapeutics, Inc. | 3.56B | -6.41% | 6,864,362 | - |
| 194 | PLSE | Pulse Biosciences, Inc. | 3.55B | -0.18% | 450,329 | 1.19M |
| 195 | VCYT | Veracyte, Inc. | 3.55B | -4.02% | 1,427,288 | 561.90M |
| 196 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.52B | -3.51% | 1,354,101 | -665.00K |
| 197 | NHC | National HealthCare Corporation | 3.50B | 1.75% | 81,706 | 1.56B |
| 198 | ACAD | Acadia Pharmaceuticals Inc. | 3.43B | -1.29% | 2,731,534 | 1.14B |
| 199 | CDNA | CareDx, Inc. | 3.43B | 1.89% | 1,718,593 | 458.09M |
| 200 | WRBY | Warby Parker Inc. | 3.40B | -1.04% | 3,611,051 | 911.61M |
| 201 | ELVN | Enliven Therapeutics, Inc. | 3.39B | 0.81% | 746,287 | - |
| 202 | OPCH | Option Care Health, Inc. | 3.38B | 0.40% | 1,614,085 | 5.69B |
| 203 | TARS | Tarsus Pharmaceuticals, Inc. | 3.31B | -4.01% | 1,242,144 | 606.33M |
| 204 | DNLI | Denali Therapeutics Inc. | 3.28B | -0.68% | 1,939,709 | 3.60M |
| 205 | RCUS | Arcus Biosciences, Inc. | 3.21B | -2.32% | 1,066,082 | 117.00M |
| 206 | ARQT | Arcutis Biotherapeutics, Inc. | 3.18B | -4.31% | 1,637,434 | 463.98M |
| 207 | RGC | Regencell Bioscience Holdings Limited | 3.14B | 1.77% | 67,829 | - |
| 208 | DYN | Dyne Therapeutics, Inc. | 2.95B | -1.80% | 3,699,419 | - |
| 209 | PGEN | Precigen, Inc. | 2.94B | -4.09% | 4,612,818 | 85.72M |
| 210 | NAMS | NewAmsterdam Pharma Company N.V. | 2.89B | -0.66% | 1,627,889 | 7.12M |
| 211 | ZLAB | Zai Lab Limited | 2.86B | -3.19% | 484,005 | 449.61M |
| 212 | TMDX | TransMedics Group, Inc. | 2.73B | -5.76% | 880,336 | 668.47M |
| 213 | ATRC | AtriCure, Inc. | 2.73B | -4.64% | 1,970,853 | 569.62M |
| 214 | MBX | MBX Biosciences, Inc. | 2.72B | -3.53% | 434,088 | - |
| 215 | AVAH | Aveanna Healthcare Holdings Inc. | 2.71B | 0.16% | 2,276,493 | 2.60B |
| 216 | NEOG | Neogen Corporation | 2.67B | -4.38% | 2,968,158 | 870.40M |
| 217 | BKD | Brookdale Senior Living Inc. | 2.59B | 0.09% | 4,733,094 | 2.93B |
| 218 | GRDN | Guardian Pharmacy Services, Inc. | 2.59B | 0.15% | 252,643 | 1.46B |
| 219 | HCM | HUTCHMED (China) Limited | 2.57B | - | 70,972 | 549.12M |
| 220 | PRVA | Privia Health Group, Inc. | 2.56B | 1.73% | 1,412,671 | 2.36B |
| 221 | CLDX | Celldex Therapeutics, Inc. | 2.53B | -0.71% | 1,443,326 | 158.00K |
| 222 | ACHC | Acadia Healthcare Company, Inc. | 2.51B | -2.07% | 1,179,498 | 3.37B |
| 223 | LQDA | Liquidia Corporation | 2.51B | -7.50% | 20,978,175 | 450.91M |
| 224 | SUPN | Supernus Pharmaceuticals, Inc. | 2.45B | -2.00% | 424,629 | 830.44M |
| 225 | IRON | Disc Medicine, Inc. | 2.44B | -2.83% | 771,796 | - |
| 226 | BEAM | Beam Therapeutics Inc. | 2.44B | -0.25% | 1,695,430 | 156.04M |
| 227 | NRIX | Nurix Therapeutics, Inc. | 2.42B | -1.56% | 1,334,901 | 36.77M |
| 228 | IMNM | Immunome, Inc. | 2.37B | -2.88% | 1,096,831 | 4.02M |
| 229 | AXGN | Axogen, Inc. | 2.34B | -4.77% | 1,600,576 | 251.17M |
| 230 | HRMY | Harmony Biosciences Holdings, Inc. | 2.30B | 0.79% | 1,227,717 | 959.90M |
| 231 | SLS | SELLAS Life Sciences Group, Inc. | 2.29B | -7.96% | 6,224,403 | - |
| 232 | UFPT | UFP Technologies, Inc. | 2.28B | -0.62% | 103,907 | 631.64M |
| 233 | NEO | NeoGenomics, Inc. | 2.28B | -3.16% | 2,469,627 | 766.30M |
| 234 | SDGR | Schrödinger, Inc. | 2.28B | -1.90% | 5,141,857 | 259.04M |
| 235 | BFLY | Butterfly Network, Inc. | 2.27B | -4.80% | 5,537,325 | 112.14M |
| 236 | ALMR | Alamar Biosciences, Inc. | 2.25B | -4.73% | 379,105 | 100.42M |
| 237 | CLOV | Clover Health Investments, Corp. | 2.25B | -1.86% | 3,052,851 | 2.48B |
| 238 | VERA | Vera Therapeutics, Inc. | 2.23B | -4.03% | 1,009,392 | - |
| 239 | ADMA | ADMA Biologics, Inc. | 2.22B | -1.00% | 3,969,774 | 512.28M |
| 240 | ADRX | ADARx Pharmaceuticals, Inc. | 2.19B | -2.01% | 962,214 | 6.13M |
| 241 | RXRX | Recursion Pharmaceuticals, Inc. | 2.18B | -1.45% | 16,075,619 | 54.86M |
| 242 | PHVS | Pharvaris N.V. | 2.18B | -2.24% | 654,341 | - |
| 243 | VRDN | Viridian Therapeutics, Inc. | 2.15B | -7.77% | 3,375,308 | 71.13M |
| 244 | BHC | Bausch Health Companies Inc. | 2.14B | -1.72% | 1,314,479 | 10.85B |
| 245 | AUPH | Aurinia Pharmaceuticals Inc. | 2.12B | -1.51% | 934,030 | 311.51M |
| 246 | PBH | Prestige Consumer Healthcare Inc. | 2.12B | -2.40% | 499,642 | 1.10B |
| 247 | WGS | GeneDx Holdings Corp. | 2.12B | -1.85% | 857,965 | 454.43M |
| 248 | MLYS | Mineralys Therapeutics, Inc. | 2.10B | -5.61% | 1,517,614 | - |
| 249 | TRLV | Trulieve Cannabis Corp. | 2.09B | -0.28% | 2,548,961 | 1.14B |
| 250 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.07B | -2.52% | 6,869,720 | 940.61M |
| 251 | GPCR | Structure Therapeutics Inc. | 2.07B | -7.32% | 1,806,650 | - |
| 252 | INSP | Inspire Medical Systems, Inc. | 2.05B | 2.05% | 1,645,201 | 898.74M |
| 253 | ADUS | Addus HomeCare Corporation | 2.04B | 1.05% | 207,256 | 1.48B |
| 254 | MD | Pediatrix Medical Group, Inc. | 2.04B | 0.12% | 678,846 | 1.95B |
| 255 | TRVI | Trevi Therapeutics, Inc. | 2.02B | -0.98% | 3,145,310 | - |
| 256 | VCEL | Vericel Corporation | 2.02B | -1.74% | 497,285 | 306.30M |
| 257 | ALVO | Alvotech | 2.01B | -3.10% | 1,201,549 | 494.61M |
| 258 | BHVN | Biohaven Ltd. | 1.98B | -1.57% | 1,269,004 | - |
| 259 | URGN | UroGen Pharma Ltd. | 1.98B | -0.20% | 624,622 | 188.73M |
| 260 | NUVB | Nuvation Bio Inc. | 1.95B | -0.71% | 3,471,211 | 169.90M |
| 261 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.95B | -2.09% | 2,377,541 | 208.78M |
| 262 | PRGO | Perrigo Company plc | 1.95B | -5.01% | 2,635,630 | 4.14B |
| 263 | AGIO | Agios Pharmaceuticals, Inc. | 1.94B | -2.32% | 1,703,742 | 98.34M |
| 264 | PVLA | Palvella Therapeutics, Inc. | 1.91B | -3.77% | 337,338 | - |
| 265 | VIR | Vir Biotechnology, Inc. | 1.91B | 0.98% | 2,575,735 | 303.23M |
| 266 | PGNY | Progyny, Inc. | 1.91B | -1.35% | 956,268 | 1.31B |
| 267 | LKFT | Lakefront Biotherapeutics NV | 1.88B | -2.66% | 341,546 | 1.13B |
| 268 | ESTA | Establishment Labs Holdings Inc. | 1.88B | -1.76% | 388,594 | 245.82M |
| 269 | MESO | Mesoblast Limited | 1.86B | -2.25% | 332,303 | 120.25M |
| 270 | SRPT | Sarepta Therapeutics, Inc. | 1.86B | -3.57% | 2,883,894 | 1.97B |
| 271 | NVCR | NovoCure Limited | 1.85B | -0.19% | 1,207,966 | 699.19M |
| 272 | FTRE | Fortrea Holdings Inc. | 1.84B | -2.76% | 1,942,460 | 2.68B |
| 273 | ABSI | Absci Corporation | 1.84B | -0.19% | 4,314,690 | 1.56M |
| 274 | ZYME | Zymeworks Inc. | 1.84B | -2.00% | 808,701 | 37.13M |
| 275 | XNCR | Xencor, Inc. | 1.84B | -0.72% | 1,094,972 | 104.97M |
| 276 | LMAT | LeMaitre Vascular, Inc. | 1.83B | -2.91% | 302,161 | 262.43M |
| 277 | ZBIO | Zenas BioPharma, Inc. | 1.82B | 3.60% | 881,852 | 1.00M |
| 278 | BLFS | BioLife Solutions, Inc. | 1.80B | -5.33% | 919,287 | 106.69M |
| 279 | SNDA | Sonida Senior Living, Inc. | 1.79B | 0.51% | 400,786 | 481.07M |
| 280 | ASTH | Astrana Health, Inc. | 1.79B | -1.86% | 266,794 | 3.84B |
| 281 | SEPN | Septerna, Inc. | 1.78B | -2.76% | 545,103 | 98.88M |
| 282 | GENB | Generate Biomedicines, Inc. | 1.77B | -8.12% | 1,216,106 | 26.48M |
| 283 | BRVE | Braveheart Bio, Inc. | 1.77B | 5.99% | 669,400 | - |
| 284 | NVAX | Novavax, Inc. | 1.75B | -1.94% | 3,147,165 | 413.80M |
| 285 | XRAY | DENTSPLY SIRONA Inc. | 1.74B | -1.35% | 5,938,118 | 3.64B |
| 286 | PSNL | Personalis, Inc. | 1.73B | -0.68% | 1,659,762 | 69.67M |
| 287 | SGRY | Surgery Partners, Inc. | 1.72B | -4.61% | 1,874,227 | 3.37B |
| 288 | NTLA | Intellia Therapeutics, Inc. | 1.70B | 0.50% | 6,638,604 | 59.51M |
| 289 | XERS | Xeris Biopharma Holdings, Inc. | 1.69B | -3.24% | 3,591,099 | 335.41M |
| 290 | FRNM | Freenome, Inc. | 1.68B | -0.70% | 585,974 | 35.41M |
| 291 | STOK | Stoke Therapeutics, Inc. | 1.68B | 0.04% | 1,161,177 | 27.59M |
| 292 | CMPS | COMPASS Pathways plc | 1.65B | -3.94% | 3,252,194 | - |
| 293 | SNDX | Syndax Pharmaceuticals, Inc. | 1.63B | -3.09% | 1,431,562 | 252.25M |
| 294 | QURE | uniQure N.V. | 1.62B | -3.27% | 3,183,995 | 18.67M |
| 295 | KMTS | Kestra Medical Technologies, Ltd. | 1.62B | -4.15% | 371,350 | 106.73M |
| 296 | ALHC | Alignment Healthcare, Inc. | 1.61B | -5.15% | 19,646,670 | 4.58B |
| 297 | NKTR | Nektar Therapeutics | 1.60B | -22.39% | 5,893,927 | 54.59M |
| 298 | OCUL | Ocular Therapeutix, Inc. | 1.60B | -4.95% | 4,513,951 | 52.06M |
| 299 | IMCR | Immunocore Holdings plc | 1.58B | 1.06% | 769,563 | 430.78M |
| 300 | RAPP | Rapport Therapeutics, Inc. | 1.58B | -2.29% | 326,774 | 20.00M |
| 301 | GHRS | GH Research PLC | 1.57B | -2.64% | 255,121 | - |
| 302 | ANIP | ANI Pharmaceuticals, Inc. | 1.56B | 0.43% | 316,689 | 978.38M |
| 303 | TSHA | Taysha Gene Therapies, Inc. | 1.54B | -2.67% | 3,847,104 | 5.49M |
| 304 | ATEC | Alphatec Holdings, Inc. | 1.53B | -4.07% | 2,284,829 | 815.05M |
| 305 | OMCL | Omnicell, Inc. | 1.53B | -1.79% | 449,405 | 1.25B |
| 306 | AZTA | Azenta, Inc. | 1.51B | -1.18% | 935,974 | 613.81M |
| 307 | ETON | Eton Pharmaceuticals, Inc. | 1.49B | 0.95% | 1,326,353 | 105.60M |
| 308 | INVA | Innoviva, Inc. | 1.48B | -3.11% | 927,047 | 440.00M |
| 309 | MAZE | Maze Therapeutics, Inc. | 1.48B | -1.95% | 589,326 | 20.00M |
| 310 | PAHC | Phibro Animal Health Corporation | 1.46B | 0.36% | 191,422 | 1.52B |
| 311 | NUTX | Nutex Health Inc. | 1.45B | 0.31% | 122,485 | 846.72M |
| 312 | ANAB | AnaptysBio, Inc. | 1.45B | -3.24% | 512,255 | 106.09M |
| 313 | NBTX | Nanobiotix S.A. | 1.45B | -10.46% | 192,407 | 13.15M |
| 314 | COAG | Hemab Therapeutics Holdings, Inc. | 1.45B | 0.71% | 437,777 | - |
| 315 | RARE | Ultragenyx Pharmaceutical Inc. | 1.45B | -1.86% | 4,120,183 | 717.00M |
| 316 | ARDT | Ardent Health, Inc. | 1.45B | -0.87% | 252,895 | 6.41B |
| 317 | TYRA | Tyra Biosciences, Inc. | 1.44B | -3.93% | 889,636 | - |
| 318 | INBX | Inhibrx Biosciences, Inc. | 1.44B | -2.15% | 216,539 | 1.30M |
| 319 | AAPG | Ascentage Pharma Group International | 1.44B | -2.51% | 4,322 | 94.61M |
| 320 | KLRA | Kailera Therapeutics, Inc. | 1.43B | -3.42% | 2,186,989 | - |
| 321 | AVBP | ArriVent BioPharma, Inc. | 1.43B | -4.46% | 591,715 | - |
| 322 | CERT | Certara, Inc. | 1.42B | 1.52% | 3,340,832 | 421.75M |
| 323 | KRSA | Korsana Biosciences, Inc. | 1.42B | -2.50% | 14,707 | - |
| 324 | HCSG | Healthcare Services Group, Inc. | 1.41B | 0.59% | 1,194,978 | 1.86B |
| 325 | AMN | AMN Healthcare Services, Inc. | 1.39B | -0.03% | 532,168 | 3.43B |
| 326 | AGL | agilon health, inc. | 1.38B | 3.38% | 235,714 | 5.92B |
| 327 | CNMD | CONMED Corporation | 1.38B | -0.65% | 169,188 | 1.37B |
| 328 | PNTG | The Pennant Group, Inc. | 1.35B | -0.54% | 348,888 | 1.10B |
| 329 | DRTS | Alpha Tau Medical Ltd. | 1.34B | -2.68% | 379,850 | - |
| 330 | OMER | Omeros Corporation | 1.34B | -2.99% | 1,236,789 | 38.42M |
| 331 | KARD | Kardigan, Inc. | 1.33B | -3.39% | 913,885 | - |
| 332 | ORIC | ORIC Pharmaceuticals, Inc. | 1.30B | -7.05% | 1,770,655 | - |
| 333 | SVRA | Savara Inc. | 1.28B | -2.23% | 2,549,516 | - |
| 334 | MNKD | MannKind Corporation | 1.27B | 1.28% | 10,190,682 | 393.63M |
| 335 | REPL | Replimune Group, Inc. | 1.27B | 1.59% | 2,517,702 | - |
| 336 | IART | Integra LifeSciences Holdings Corporation | 1.25B | -1.17% | 652,923 | 1.65B |
| 337 | OMDA | Omada Health, Inc. | 1.25B | -1.92% | 1,437,499 | 309.76M |
| 338 | DMRA | Damora Therapeutics, Inc. | 1.25B | -4.93% | 354,650 | - |
| 339 | USPH | U.S. Physical Therapy, Inc. | 1.23B | -3.65% | 106,871 | 804.27M |
| 340 | AVLN | Avalyn Pharma Inc. | 1.22B | -3.76% | 423,591 | - |
| 341 | TRAX | First Tracks Biotherapeutics, Inc. | 1.21B | -4.29% | 564,140 | - |
| 342 | BCAX | Bicara Therapeutics Inc. | 1.20B | -2.20% | 697,907 | - |
| 343 | LBRX | LB Pharmaceuticals Inc | 1.20B | -2.87% | 278,885 | - |
| 344 | INNV | InnovAge Holding Corp. | 1.20B | - | 461,960 | 989.71M |
| 345 | CRON | Cronos Group Inc. | 1.18B | -2.73% | 1,318,771 | 179.09M |
| 346 | OPK | OPKO Health, Inc. | 1.17B | -2.48% | 2,188,501 | 587.90M |
| 347 | IMTX | Immatics N.V. | 1.15B | -3.87% | 639,725 | 47.65M |
| 348 | TNDM | Tandem Diabetes Care, Inc. | 1.15B | 1.16% | 2,401,707 | 1.04B |
| 349 | HROW | Harrow, Inc. | 1.15B | -0.62% | 596,836 | 275.59M |
| 350 | BVS | Bioventus Inc. | 1.13B | -1.32% | 509,282 | 581.85M |
| 351 | STAA | STAAR Surgical Company | 1.12B | -1.02% | 776,262 | 339.59M |
| 352 | GDRX | GoodRx Holdings, Inc. | 1.12B | -0.61% | 1,109,252 | 785.23M |
| 353 | LTGO | Latigo Biotherapeutics, Inc. | 1.11B | -0.06% | 436,666 | - |
| 354 | IRMD | IRADIMED CORPORATION | 1.09B | -1.07% | 174,655 | 86.34M |
| 355 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.08B | -1.78% | 530,990 | 730.02M |
| 356 | CSTL | Castle Biosciences, Inc. | 1.08B | -0.77% | 522,288 | 357.28M |
| 357 | AORT | Artivion, Inc. | 1.07B | -3.90% | 501,657 | 471.47M |
| 358 | VOR | Vor Biopharma Inc. | 1.07B | -5.35% | 876,284 | - |
| 359 | ENOV | Enovis Corporation | 1.04B | -1.20% | 857,614 | 2.30B |
| 360 | JANX | Janux Therapeutics, Inc. | 1.04B | -1.85% | 837,451 | 24.00M |
| 361 | TDOC | Teladoc Health, Inc. | 1.03B | -2.24% | 3,421,688 | 2.49B |
| 362 | AKTS | Aktis Oncology, Inc. | 1.03B | -4.88% | 305,210 | 10.06M |
| 363 | MGTX | MeiraGTx Holdings plc | 1.02B | -3.09% | 1,066,040 | 397.50M |
| 364 | ANL | Adlai Nortye Group Ltd. | 1.01B | -1.50% | 122,316 | 18.06M |
| 365 | SPTX | Seaport Therapeutics, Inc. | 1.01B | -6.05% | 330,171 | - |
| 366 | PCRX | Pacira BioSciences, Inc. | 997.34M | -0.12% | 510,596 | 746.16M |
| 367 | BBNX | Beta Bionics, Inc. | 993.35M | -0.58% | 874,100 | 119.01M |
| 368 | ANRO | Alto Neuroscience, Inc. | 993.22M | -0.86% | 575,791 | - |
| 369 | ODTX | Odyssey Therapeutics, Inc. | 978.49M | -8.10% | 308,442 | 99.00K |
| 370 | MLTX | MoonLake Immunotherapeutics | 976.17M | -1.97% | 1,305,142 | - |
| 371 | PRCT | PROCEPT BioRobotics Corporation | 974.80M | -6.59% | 1,604,671 | 337.34M |
| 372 | LMRI | Lumexa Imaging Holdings, Inc. | 971.32M | -1.37% | 379,508 | 1.04B |
| 373 | GLUE | Monte Rosa Therapeutics, Inc. | 960.63M | -5.62% | 2,867,931 | 28.73M |
| 374 | KURA | Kura Oncology, Inc. | 947.43M | -0.56% | 2,135,205 | 77.23M |
| 375 | APMD | Apnimed, Inc. | 938.36M | 2.88% | 747,357 | 115.12M |
| 376 | CGEM | Cullinan Therapeutics, Inc. | 935.07M | -5.34% | 910,795 | - |
| 377 | ALMS | Alumis Inc. | 933.23M | -2.44% | 2,130,423 | 7.40M |
| 378 | HSTM | HealthStream, Inc. | 928.89M | 2.19% | 191,673 | 321.12M |
| 379 | CRVS | Corvus Pharmaceuticals, Inc. | 919.44M | -5.12% | 1,308,966 | - |
| 380 | SLBT | SL Science Holding Limited | 912.43M | -5.88% | 34,294 | 3.27M |
| 381 | CBLL | CeriBell, Inc. | 906.11M | -3.20% | 316,701 | 101.96M |
| 382 | ABUS | Arbutus Biopharma Corporation | 902.19M | -4.60% | 16,620,278 | 181.72M |
| 383 | SGP | SpyGlass Pharma, Inc. | 886.37M | 1.92% | 101,101 | - |
| 384 | RIGL | Rigel Pharmaceuticals, Inc. | 877.39M | -2.45% | 234,997 | 276.79M |
| 385 | JBIO | Jade Biosciences, Inc. | 875.74M | -1.99% | 1,071,523 | - |
| 386 | AHG | Akso Health Group | 873.84M | 13.33% | 237,691 | 13.83M |
| 387 | HELP | Cybin Inc. | 870.15M | -3.09% | 1,327,956 | - |
| 388 | SANA | Sana Biotechnology, Inc. | 865.15M | -0.86% | 3,378,914 | - |
| 389 | IMMX | Immix Biopharma, Inc. | 848.10M | -1.68% | 1,646,047 | - |
| 390 | ARDX | Ardelyx, Inc. | 842.25M | -1.17% | 4,107,152 | 450.89M |
| 391 | DNA | Ginkgo Bioworks Holdings, Inc. | 841.75M | -2.57% | 2,911,077 | 132.42M |
| 392 | SIBN | SI-BONE, Inc. | 824.66M | -2.13% | 652,985 | 213.60M |
| 393 | OBX | Obsidian Therapeutics, Inc. | 822.81M | -2.99% | 299,804 | - |
| 394 | ATTO | Attovia Therapeutics, Inc. | 812.14M | 3.79% | 530,721 | 1.80M |
| 395 | IVA | Inventiva S.A. | 810.04M | -6.23% | 5,324,999 | 2.81M |
| 396 | LXRX | Lexicon Pharmaceuticals, Inc. | 809.82M | -2.93% | 2,271,314 | 41.47M |
| 397 | INMD | InMode Ltd. | 807.60M | -0.85% | 561,657 | 374.63M |
| 398 | AVTX | Avalo Therapeutics, Inc. | 801.77M | -2.48% | 932,348 | 59.00K |
| 399 | ANNX | Annexon, Inc. | 781.07M | -2.60% | 3,919,068 | - |
| 400 | PACB | Pacific Biosciences of California, Inc. | 780.19M | 5.91% | 35,855,869 | 159.27M |
| 401 | VREX | Varex Imaging Corporation | 779.32M | 0.22% | 484,960 | 865.00M |
| 402 | CADL | Candel Therapeutics, Inc. | 777.43M | -2.68% | 1,037,606 | - |
| 403 | GERN | Geron Corporation | 777.39M | -1.63% | 13,253,057 | 204.56M |
| 404 | ACHV | Achieve Life Sciences, Inc. | 774.86M | -6.92% | 1,153,521 | - |
| 405 | DSGN | Design Therapeutics, Inc. | 766.00M | -2.63% | 346,533 | - |
| 406 | FDMT | 4D Molecular Therapeutics, Inc. | 764.58M | -3.28% | 655,462 | 92.01M |
| 407 | WVE | Wave Life Sciences, Inc. | 764.55M | 4.86% | 5,413,706 | 65.37M |
| 408 | AHCO | AdaptHealth Corp. | 757.76M | 0.71% | 2,027,934 | 3.36B |
| 409 | CTKB | Cytek Biosciences, Inc. | 755.20M | -2.52% | 1,571,590 | 206.71M |
| 410 | SLDB | Solid Biosciences Inc. | 748.43M | -3.46% | 1,582,130 | - |
| 411 | GYRE | Gyre Therapeutics, Inc. | 742.24M | -4.50% | 139,996 | 109.82M |
| 412 | AVR | Anteris Technologies Global Corp. | 741.66M | -2.06% | 1,170,680 | 2.24M |
| 413 | GMRS | GMR Solutions Inc. | 732.14M | -2.18% | 2,089,597 | 5.88B |
| 414 | FTH | Faeth Therapeutics, Inc. | 730.51M | -4.94% | 268,478 | - |
| 415 | OABI | OmniAb, Inc. | 725.50M | 0.60% | 1,981,634 | 38.46M |
| 416 | OLMA | Olema Pharmaceuticals, Inc. | 723.61M | -4.28% | 859,865 | - |
| 417 | VSTM | Verastem, Inc. | 715.45M | -1.86% | 1,762,498 | 87.53M |
| 418 | QDEL | QuidelOrtho Corporation | 711.81M | -1.52% | 2,768,208 | 2.67B |
| 419 | COLL | Collegium Pharmaceutical, Inc. | 711.34M | 0.14% | 1,000,104 | 808.21M |
| 420 | PHAR | Pharming Group N.V. | 705.87M | -0.40% | 12,087 | 366.48M |
| 421 | STTK | Shattuck Labs, Inc. | 686.48M | 0.29% | 2,023,928 | 1.00M |
| 422 | SOPH | SOPHiA GENETICS SA | 683.58M | -4.18% | 700,870 | 86.17M |
| 423 | MDXG | MiMedx Group, Inc. | 676.33M | -0.43% | 1,189,162 | 355.17M |
| 424 | NVCT | Nuvectis Pharma, Inc. | 675.09M | -1.89% | 168,250 | - |
| 425 | ETRA | Electra Therapeutics, Inc. | 670.35M | -5.07% | 1,255,362 | - |
| 426 | SGMT | Sagimet Biosciences Inc. | 664.41M | -5.16% | 2,008,343 | - |
| 427 | DBVT | DBV Technologies S.A. | 653.00M | -4.68% | 564,493 | 5.04M |
| 428 | ACRS | Aclaris Therapeutics, Inc. | 649.15M | -16.16% | 5,176,705 | 8.22M |
| 429 | SLN | Silence Therapeutics plc | 644.84M | -2.01% | 1,578,910 | 615.00K |
| 430 | PHR | Phreesia, Inc. | 643.05M | 0.29% | 494,120 | 507.79M |
| 431 | CLYM | Climb Bio, Inc. | 635.82M | -3.49% | 952,933 | - |
| 432 | STLN | Starling Oncology, Inc. | 633.41M | -1.66% | 994,173 | 587.24M |
| 433 | AURA | Aura Biosciences, Inc. | 626.38M | -3.82% | 807,321 | - |
| 434 | ANGO | AngioDynamics, Inc. | 624.95M | -1.69% | 685,128 | 320.17M |
| 435 | IRWD | Ironwood Pharmaceuticals, Inc. | 621.30M | -5.29% | 2,637,428 | 389.32M |
| 436 | CBIO | Crescent Biopharma, Inc. | 610.34M | -2.26% | 300,848 | 11.88M |
| 437 | EVO | Evotec SE | 605.97M | -3.80% | 119,043 | 819.47M |
| 438 | ZVRA | Zevra Therapeutics, Inc. | 604.53M | -7.20% | 1,301,116 | 136.07M |
| 439 | BLSM | BlossomHill Therapeutics, Inc. | 590.88M | -0.27% | 152,580 | - |
| 440 | WEAV | Weave Communications, Inc. | 590.39M | - | 1,522,109 | 257.79M |
| 441 | FLGT | Fulgent Genetics, Inc. | 586.08M | -3.27% | 338,221 | 323.93M |
| 442 | CRMD | CorMedix Inc. | 578.35M | -3.64% | 1,051,477 | 462.25M |
| 443 | CTMX | CytomX Therapeutics, Inc. | 573.08M | -3.31% | 2,697,823 | 18.30M |
| 444 | KIDS | OrthoPediatrics Corp. | 566.32M | -2.60% | 188,761 | 252.72M |
| 445 | PHAT | Phathom Pharmaceuticals, Inc. | 562.37M | -3.01% | 1,059,748 | 239.66M |
| 446 | VALN | Valneva SE | 557.50M | -4.61% | 34,509 | 163.30M |
| 447 | AQST | Aquestive Therapeutics, Inc. | 557.27M | -4.10% | 2,683,347 | 54.09M |
| 448 | YDES | YD Bio Limited | 553.19M | 5.26% | 267,151 | 1.24M |
| 449 | SSII | SS Innovations International, Inc. | 551.06M | -7.72% | 108,146 | 52.40M |
| 450 | OCS | Oculis Holding AG | 540.77M | -6.21% | 578,445 | 1.45M |
| 451 | ALT | Altimmune, Inc. | 536.87M | -3.50% | 3,589,212 | 31.00K |
| 452 | MPLT | MapLight Therapeutics, Inc. | 535.19M | -5.50% | 432,223 | - |
| 453 | DCTH | Delcath Systems, Inc. | 534.71M | -3.51% | 468,116 | 95.42M |
| 454 | ALLO | Allogene Therapeutics, Inc. | 532.06M | -3.75% | 4,153,994 | 4.64M |
| 455 | PRME | Prime Medicine, Inc. | 531.93M | -2.13% | 2,827,843 | 4.07M |
| 456 | NGNE | Neurogene Inc. | 531.30M | -4.57% | 152,116 | 925.00K |
| 457 | SENS | Senseonics Holdings, Inc. | 526.63M | -2.06% | 606,428 | 48.55M |
| 458 | MNPR | Monopar Therapeutics Inc. | 523.35M | -2.13% | 130,790 | - |
| 459 | CAPR | Capricor Therapeutics, Inc. | 519.76M | -5.60% | 3,531,332 | 11.13M |
| 460 | EPRX | Eupraxia Pharmaceuticals Inc. | 517.54M | -13.96% | 3,645,195 | - |
| 461 | MASS | 908 Devices Inc. | 517.08M | 1.38% | 595,205 | 60.84M |
| 462 | PROK | ProKidney Corp. | 516.97M | 3.01% | 1,503,513 | 818.00K |
| 463 | PBYI | Puma Biotechnology, Inc. | 507.94M | -0.91% | 518,400 | 231.24M |
| 464 | EOLS | Evolus, Inc. | 507.93M | -3.87% | 922,567 | 316.49M |
| 465 | BWAY | BrainsWay Ltd. | 506.80M | -4.55% | 137,905 | 60.70M |
| 466 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 467 | GLAS | Glass House Brands Inc. | 501.37M | -5.17% | 2,640,586 | 176.98M |
| 468 | ENTX | Entera Bio Ltd. | 500.38M | -0.69% | 640,826 | 42.00K |
| 469 | SGHT | Sight Sciences, Inc. | 497.44M | -3.53% | 339,271 | 83.38M |
| 470 | AUTL | Autolus Therapeutics plc | 492.40M | -4.64% | 1,419,616 | 117.39M |
| 471 | TCMD | Tactile Systems Technology, Inc. | 491.78M | -2.60% | 205,876 | 350.31M |
| 472 | DRUG | Bright Minds Biosciences Inc. | 491.05M | -1.22% | 166,857 | - |
| 473 | RGNX | REGENXBIO Inc. | 489.82M | -1.46% | 1,705,118 | 174.48M |
| 474 | TLRY | Tilray Brands, Inc. | 489.06M | -4.80% | 7,027,262 | 915.45M |
| 475 | CTNM | Contineum Therapeutics, Inc. | 488.70M | -3.20% | 773,990 | - |
| 476 | ARVN | Arvinas, Inc. | 485.82M | -3.94% | 807,022 | 316.70M |
| 477 | TKNO | Alpha Teknova, Inc. | 475.68M | -0.45% | 344,304 | 43.70M |
| 478 | KMDA | Kamada Ltd. | 475.28M | -3.07% | 93,643 | 191.85M |
| 479 | OVID | Ovid Therapeutics Inc. | 474.57M | -2.41% | 1,349,461 | 1.58M |
| 480 | NRC | NRC Health | 471.59M | 0.61% | 176,152 | 140.00M |
| 481 | CERS | Cerus Corporation | 467.54M | -2.52% | 1,924,547 | 221.55M |
| 482 | ASMB | Assembly Biosciences, Inc. | 467.28M | -2.30% | 350,802 | 74.85M |
| 483 | NPCE | NeuroPace, Inc. | 451.36M | -4.43% | 197,398 | 106.99M |
| 484 | DMAC | DiaMedica Therapeutics Inc. | 450.28M | 0.97% | 234,218 | - |
| 485 | TECX | Tectonic Therapeutic, Inc. | 443.18M | -2.66% | 343,504 | - |
| 486 | PRTA | Prothena Corporation plc | 438.42M | 1.91% | 457,089 | 54.53M |
| 487 | SRTA | Strata Critical Medical, Inc. | 427.29M | -5.48% | 1,614,497 | 255.98M |
| 488 | RZLT | Rezolute, Inc. | 426.93M | -1.69% | 981,218 | - |
| 489 | AGMB | AgomAb Therapeutics NV | 425.99M | -22.07% | 639,184 | - |
| 490 | SPRY | ARS Pharmaceuticals, Inc. | 409.72M | -4.41% | 1,971,550 | 116.93M |
| 491 | AVIR | Atea Pharmaceuticals, Inc. | 408.24M | -2.30% | 408,661 | - |
| 492 | KYTX | Kyverna Therapeutics, Inc. | 403.22M | -4.12% | 788,199 | - |
| 493 | EIKN | Eikon Therapeutics, Inc. | 401.36M | -7.84% | 624,564 | - |
| 494 | ZURA | Zura Bio Limited | 396.73M | -0.48% | 2,913,585 | - |
| 495 | TTRX | Turn Therapeutics Inc. | 396.48M | -7.51% | 121,916 | - |
| 496 | VTVT | vTv Therapeutics Inc. | 395.73M | 3.27% | 34,271 | 36.84M |
| 497 | PRLD | Prelude Therapeutics Incorporated | 391.38M | -2.81% | 502,491 | 22.42M |
| 498 | RLMD | Relmada Therapeutics, Inc. | 390.41M | -2.92% | 1,358,327 | - |
| 499 | SI | Shoulder Innovations, Inc. | 390.36M | -0.79% | 176,914 | 60.06M |
| 500 | MYGN | Myriad Genetics, Inc. | 388.34M | -5.80% | 1,657,898 | 806.60M |